Understanding Gut Immune Cells and Early Life Development
Characterization of Mucosal Lymphocytes
This project explores how immune cells in the gut develop early in life and how this affects our ability to fight off infections and prevent conditions like colitis later on.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Brigham and Women's Hospital NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-11124792 on NIH RePORTER |
What this research studies
Our bodies have special immune cells called iNKT cells in the gut that help keep us healthy by interacting with the good bacteria there. This research looks at how these important cells are set up during childhood, especially how certain cells in the gut lining and the bacteria we encounter influence them. We want to understand the exact steps involved in creating a healthy environment for these immune cells, which could protect against gut diseases. By learning these early-life mechanisms, we hope to find new ways to prevent conditions like colitis and other mucosal diseases.
Who could benefit from this research
Good fit: Patients who might benefit from future treatments developed from this research include those with inflammatory bowel diseases like colitis, or individuals susceptible to mucosal infections.
Not a fit: Patients without conditions related to gut immunity, inflammation, or mucosal diseases may not directly benefit from this specific research.
Why it matters
Potential benefit: If successful, this work could lead to new strategies for preventing or treating inflammatory bowel diseases and other gut-related conditions by targeting early-life development of immune cells.
How similar studies have performed: This research builds upon recent discoveries by the same team regarding the role of specific stromal cells and macrophages in regulating gut immune cells.
Where this research is happening
Boston, United States
- Brigham and Women's Hospital — Boston, United States (Active)
Researchers
- Principal investigator: Blumberg, Richard S — Brigham and Women's Hospital
- Study coordinator: Blumberg, Richard S
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.